On February 17, 2021, Ziopharm Oncology, Inc. appointed Timothy Cunningham, as the Company's interim Chief Financial Officer, effective immediately. Mr. Cunningham brings over 30 years of extensive finance and operations leadership experience in the biotechnology and software industries. He has been employed by Danforth Advisors, LLC since September 2020, providing financial consulting services on a project/interim basis for public and private life sciences companies.